Cargando…
Recombinant human TSH versus thyroid hormone withdrawal in adjuvant therapy with radioactive iodine of patients with papillary thyroid carcinoma and clinically apparent lymph node metastases not limited to the central compartment (cN1b)
OBJECTIVE: To compare the short- and long-term outcomes of adjuvant therapy with radioactive iodine (RAI) preceded by the administration of recombinant human TSH (rhTSH) versus thyroid hormone withdrawal (THW) in patients with papillary thyroid carcinoma and clinically apparent lymph node metastases...
Autores principales: | Rosario, Pedro Weslley, Mourão, Gabriela Franco, Calsolari, Maria Regina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Sociedade Brasileira de Endocrinologia e Metabologia
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10118864/ https://www.ncbi.nlm.nih.gov/pubmed/28226001 http://dx.doi.org/10.1590/2359-3997000000247 |
Ejemplares similares
-
Serum TSH level stability after 5 years in euthyroid adults at low risk for thyroid dysfunction
por: Rosario, Pedro Weslley, et al.
Publicado: (2018) -
Influence of chronic lymphocytic thyroiditis on the risk of persistent and recurrent disease in patients with papillary thyroid carcinoma and elevated antithyroglobulin antibodies after initial therapy()
por: Côrtes, Marina Carvalho S., et al.
Publicado: (2017) -
Is Stimulated Thyroglobulin Necessary after Ablation in All Patients with Papillary Thyroid Carcinoma and Basal Thyroglobulin Detectable by a Second-Generation Assay?
por: Rosario, Pedro Weslley, et al.
Publicado: (2015) -
“Adjuvant Radioactive iodine 133 ablation in papillary microcarcinoma of thyroid: Saudi Arabian experience”
por: AL-Qahtani, Khalid Hussain, et al.
Publicado: (2015) -
TSH reference values in the first trimester of gestation and correlation between maternal TSH and obstetric and neonatal outcomes: a prospective Brazilian study
por: Rosario, Pedro Weslley, et al.
Publicado: (2015)